Blick ins Buch

Polypharmacology in Drug Discovery (eBook)

eBook Download: PDF | EPUB

2012 | 1. Auflage
536 Seiten
Wiley (Verlag)
978-1-118-09813-4 (ISBN)

Lese- und Medienproben

Ebook-Leseprobe (EPUB)

An essential outline of the main facets of polypharmacology in drug discovery research Extending drug discovery opportunities beyond the "e;one drug, one target"e; philosophy, a polypharmacological approach to the treatment of complex diseases is emerging as a hot topic in both industry and academic research. Polypharmacology in Drug Discovery presents an overview of the various facets of polypharmacology and how it can be applied as an innovative concept for developing medicines for treating bacterial infections, epilepsy, cancer, psychiatric disorders, and more. Filled with a collection of instructive case studies that reinforce the material and illuminate the subject, this practical guide: Covers the two-sided nature of polypharmacology its contribution to adverse drug reactions and its benefit in certain therapeutic drug classes Addresses the important topic of polypharmacology in drug discovery, a subject that has not been thoroughly covered outside of scattered journal articles Overviews state-of-the-art approaches and developments to help readers understand concepts and issues related to polypharmacology Fosters interdisciplinary drug discovery research by embracing computational, synthetic, in vitro and in vivo pharmacological and clinical aspects of polypharmacology A clear road map for helping readers successfully navigate around the problems involved with promiscuous ligands and targets, Polypharmacology in Drug Discovery provides real examples, in-depth explanations and discussions, and detailed reviews and opinions to spark inspiration for new drug discovery projects.

Jens-Uwe Peters, PhD, works in the Medicinal Chemistry Department at F. Hoffmann-La Roche. In his ten years at Roche, he has been involved in numerous drug discovery projects, has contributed to Early Safety Profiling initiatives, and has researched opportunities for polypharmacological drug discovery. Dr. Peters is author or coauthor on twenty-six journal papers and is named on twenty-two patents.

"The book is well presented and the price is reasonable
for anyone (drug designers, medicinal chemists, biochemists,
biologists, clinicians and toxicologists) interested in any of the
many facets that come together to make
polypharmacology." (British Toxicology Society,
1 July 2013)

"However, anyone interested in the complex issues relating
to drug promiscuity should find this very timely and topical book
to be a reliable and stimulating reference that they will revisit
many times." (ChemMedChem, 2012)

"Only recently, the characterization of promiscuous
ligands turned from 'dirty drugs' into 'agents
being rich in pharmacology.' ... Polypharmacology in
Drug Discovery covers all aspects, the good, the bad and the
ugly. On the one hand, a lack of specificity (the
'bad') causes more or less serious side effects;
inhibition of certain antitargets (the 'ugly'), e.g.
the hERG channel, results in a termination of a development
project, in the past even the withdrawal of already marketed drugs;
on the other hand, a desired promiscuity (the 'good')
may be beneficial, e.g. in the case of certain CNS drugs and of
anti-tumor kinase inhibitors. In Peters' book, all these
topics are discussed in great detail by internationally leading
authors. Therefore, Polypharmacology in Drug Discovery is of
utmost importance for all drug designers, medicinal chemists as
well as biochemists and biologists. The price of the book is in
excellent relationship to its 500 pages and the overall quality, in
content and presentation."--Prof. Dr. Hugo Kubinyi

Erscheint lt. Verlag	20.1.2012
Sprache	englisch
Themenwelt	Medizin / Pharmazie ► Gesundheitsfachberufe
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
	Naturwissenschaften ► Chemie
Schlagworte	Chemie • Chemistry • Computational Chemistry & Molecular Modeling • Computational Chemistry u. Molecular Modeling • Drug Discovery & Development • Medical Science • Medizin • Pharmacology & Pharmaceutical Medicine • Pharmakologie u. Pharmazeutische Medizin • Wirkstoffforschung • Wirkstoffforschung u. -entwicklung
ISBN-10	1-118-09813-7 / 1118098137
ISBN-13	978-1-118-09813-4 / 9781118098134

Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?

PDF (Adobe DRM)
Größe: 6,5 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUB (Adobe DRM)
Größe: 8,9 MB

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Andere eBook-Ausgabe

PDF (Adobe DRM)
EPUB (Adobe DRM)